We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Orexigen Gets Interim OK For $7.5M DIP To Fund Sale Process

Law360, Wilmington (March 13, 2018, 11:10 PM EDT) -- Bankrupt prescription weight-loss treatment maker Orexigen Therapeutics Inc. received interim approval Tuesday in Delaware for access to $7.5 million in debtor-in-possession financing as part of a larger $70 million package....
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.